About the Authors
- Nigam H. Shah
-
Contributed equally to this work with: Nigam H. Shah, Paea LePendu
* E-mail: nigam@stanford.edu
Affiliation Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, CA, United States of America
- Paea LePendu
-
Contributed equally to this work with: Nigam H. Shah, Paea LePendu
Affiliation Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, CA, United States of America
- Anna Bauer-Mehren
-
Affiliation Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, CA, United States of America
- Yohannes T. Ghebremariam
-
Affiliation Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX, United States of America
- Srinivasan V. Iyer
-
Affiliation Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, CA, United States of America
- Jake Marcus
-
Affiliation Practice Fusion, Inc., San Francisco, CA, United States of America
- Kevin T. Nead
-
Affiliation Divisions of Cardiovascular Medicine and Vascular Surgery, Stanford University, Stanford, CA, United States of America
- John P. Cooke
-
Affiliation Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX, United States of America
- Nicholas J. Leeper
-
Affiliation Divisions of Cardiovascular Medicine and Vascular Surgery, Stanford University, Stanford, CA, United States of America
Competing Interests
PL, ABM, SVI, and NHS are inventors on technology disclosures and/or patents, name: Methods for Ontology based Analytics and numbers: US13/273,038, US13/420,402, US13/424,375, and US13/424,376, owned by Stanford University, that enable the use of clinical text for data-mining. JPC and YTG are inventors on patents titled: Dimethylarginine Dimethylaminohydrolase Inhibitors and Methods of Use Thereof and number: US13/766,336, owned by Stanford University, that protect the use of agents that therapeutically modulate the DDAH/NOS pathway. YTG and JPC are also founders of Altitude Pharma, Inc., a biotechnology Company that is developing PPI-based products for airway diseases. Apixio, Inc. partly funded this study. JM is an employee of Practice Fusion, Inc., which owns inventions by JM. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: NHS JPC NJL PL ABM SVI. Performed the experiments: YTG. Analyzed the data: JM KTN. Contributed reagents/materials/analysis tools: PL ABM SVI. Wrote the paper: NHS PL NJL. Participated in the editing of the manuscript: NHS PL ABM YTG SVI JM KTN JPC NJL.